Prostatic Neoplasms: Clinical Trials

13 trials for Prostatic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 terminated. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Terminated 13

Follow Prostatic Neoplasms: new trials by email Literature Review of Prostatic Neoplasms trials Research Report on Prostatic Neoplasms

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Contributions to Hypertension With Androgen Deprivation Therapy
Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer
Phase 4TerminatedUniversity of Colorado, Denver102023-09-202026-09-02
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
.5% Bupivacaine - Prostate Cancer, Hot Flashes
Phase 4TerminatedNorthwestern University12019-11-132023-01-25
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 4TerminatedM.D. Anderson Cancer Center22019-09-192025-01-16
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, 0.9% Sodium Chloride Injection - Kidney Cancer, Prostate Cancer
Phase 4TerminatedUniversity of Missouri-Columbia212019-02-262023-10-25
PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
Subcutaneous Heparin - Prostate Cancer, Venous Thromboembolism
Phase 4TerminatedJohns Hopkins University5012017-07-012020-08-05
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Enzalutamide - Metastatic Castration Resistant Prostate Cancer
Phase 4TerminatedAstellas Pharma Global Development, Inc.42015-10-282018-04-19
A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease
Eligard - Metastatic Prostate Cancer
Phase 4TerminatedAstellas Pharma Europe Ltd.12014-08-012017-03-09
Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning
Prostate HistoScanning - Prostate Cancer
Phase 4TerminatedAdvanced Medical Diagnostics s.a.802013-10-012015-01-05
GP Extended Action Triptorelin
Decapeptyl® SR 22.5mg, Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg - Prostate Cancer
Phase 4TerminatedIpsen272012-08-012025-05-23
Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy
Robotic Radical Prostatectomy, Open Radical Prostatectomy - Prostatic Neoplasms, Adenocarcinoma
Phase 4TerminatedMayo Clinic102011-05-012014-06-02
Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial
Radical prostatectomy with implantation of allograft, Radical prostatectomy without implantation of allograft - Erectile Dysfunction Following Radical Prostatectomy
Phase 4TerminatedKantonsspital Winterthur KSW302011-01-012021-02-21
Dissemination of Prostate Cancer Screening to PCP's in African American Communities
Academic Detailing - Prostate Cancer
Phase 4TerminatedColumbia University862004-01-012015-10-14
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Trelstar, Lupron, Zoladex - Prostate Cancer
Phase 4TerminatedPharmatech412002-09-012016-04-25

Narrower conditions

Adenocarcinoma (1)  ·  Hot Flashes (1)  ·  Hypertension (1)  ·  Kidney Diseases (1)  ·  Kidney Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Primary Dysautonomias (1)  ·  Pulmonary Embolism (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Broader conditions

Genital Diseases (13)  ·  Genital Diseases, Male (13)  ·  Genital Neoplasms, Male (13)  ·  Male Urogenital Diseases (13)  ·  Neoplasms by Site (13)  ·  Prostatic Diseases (13)  ·  Urogenital Diseases (13)  ·  Urogenital Neoplasms (13)  ·  Neoplasms (12)  ·  Cardiovascular Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urologic Diseases (2)  ·  Vascular Diseases (2)

Interventions

Goserelin (3)  ·  Leuprolide (3)  ·  Triptorelin Pamoate (2)  ·  enzalutamide (2)  ·  Bupivacaine (1)  ·  Flutamide (1)  ·  Glucose (1)  ·  Lidocaine (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Receptors, Androgen (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Solutions (1)  ·  bicalutamide (1)  ·  fluciclovine F-18 (1)

Sponsors

Advanced Medical Diagnostics s.a. (1)  ·  Astellas Pharma Europe Ltd. (1)  ·  Astellas Pharma Global Development, Inc. (1)  ·  Columbia University (1)  ·  Ipsen (1)  ·  Johns Hopkins University (1)  ·  Kantonsspital Winterthur KSW (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Northwestern University (1)  ·  Pharmatech (1)  ·  University of Colorado, Denver (1)  ·  University of Missouri-Columbia (1)

Countries

United States (8)  ·  Netherlands (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Latvia (1)

Top investigators

Bertrand Tombal, Prof (1)  ·  Boris Mraovic, MD (1)  ·  David Walega, MD, MS (1)  ·  Gregory C Ravizzini (1)  ·  Hubert John, Chefarzt (1)  ·  Matthew Babcock, PhD (1)  ·  Michael Michael Manyak, MD (1)  ·  Mohamad E Allaf, MD (1)  ·  Sherri Sheinfeld Gorin, PhD (1)

Results publications

PMID 30352714, PMID 31643128, PMID 32444264